Page 43

Target No. 3

NEUROSCIENCES Faculty from over 13 basic and clinical science departments at Temple now participate in neuroscience research focused on neurodegeneration, neuroinfection, neuroinflammation, and neurooncology. In these areas, Temple researchers—basic scientists working side by side with clinicians—seek to understand the molecular events that lead to devastating diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, AIDS dementia, cerebral palsy, and pediatric and adult brain tumors. The goal is to create better tests and more effective therapies. The Temple Neurosciences Program first gained international recognition for its pioneering work in neurovirology and especially neuroAIDS. This deep expertise in the pathogenesis of neurotropic viruses has led to important findings in both viral and non-viral associated neurologic disorders. This special focus also played a role in the National Institute of Mental Health recently awarding Temple an $8 million grant for the Comprehensive NeuroAIDS Core Center. Now, as promising treatment leads emerge, this group has attracted additional funding to speed multidisciplinary translation efforts. A new laboratory for the Center for Neurovirology and Department of Neuroscience has been built, additional faculty have been hired, and several joint international research efforts are underway.

NEUROSCIENCES

39

Profile for Temple Health

Temple University School of Medicine - Highlights of Basic and Clinical Research - 2014  

Temple University School of Medicine is pushing the boundaries of science to help reduce the devastating effects of heart and lung disease,...

Temple University School of Medicine - Highlights of Basic and Clinical Research - 2014  

Temple University School of Medicine is pushing the boundaries of science to help reduce the devastating effects of heart and lung disease,...